Cleared Traditional

K080799 - ATLAS-BASED AUTOSEGMENTATION

K080799 is an FDA 510(k) clearance for ATLAS-BASED AUTOSEGMENTATION, manufactured by Computerized Medical Systems, Inc.. The device is a Class 2 Radiology device with product code LHN cleared through the Traditional 510(k) pathway after a 139-day FDA review.

K080799 · Computerized Medical Systems, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2008
Decision
139d
Days
Class 2
Risk

K080799 is an FDA 510(k) clearance for the ATLAS-BASED AUTOSEGMENTATION. Classified as System, Radiation Therapy, Charged-particle, Medical (product code LHN), Class II - Special Controls.

Submitted by Computerized Medical Systems, Inc. (St. Louis, US). The FDA issued a Cleared decision on August 7, 2008 after a review of 139 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Computerized Medical Systems, Inc. devices

FDA 510(k) Submission Details - K080799

510(k) Number K080799 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 21, 2008
Decision Date August 07, 2008
Days to Decision 139 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d slower than avg
Panel avg: 107d · This submission: 139d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LHN Device Classification - Class 2, Special Controls

Product Code LHN System, Radiation Therapy, Charged-particle, Medical
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LHN System, Radiation Therapy, Charged-particle, Medical

All 88
Devices cleared under the same product code (LHN) and FDA review panel - the closest regulatory comparables to K080799.
PROTEUS 235 PROTON THERAPY SYSTEM
K091629 · Ion Beam Applications S.A. · Aug 2009
IBA PROTON THERAPY SYSTEM - PROTEUS 235
K083058 · Ion Beam Applications S.A. · Apr 2009
IBA PROTON THERAPY SYSTEM- PROTEUS 235
K082416 · Ion Beam Applications S.A. · Dec 2008
IPLAN RT IMAGE
K080886 · Brainlab AG · Jun 2008
PROBEAT WITH DISCRETE SPOT SCANNING SYSTEM
K073059 · Hitachi, Ltd., Power Systems Group · Dec 2007
DOSE VERIFICATION SYSTEM PATIENT DOSIMETRY SYSTEM, MODEL DVS-I-11: DVS INSERTION TOOL, DVS-D-A: DVS DOSIMETER, DVS-R-100
K071399 · Sicel Technologies, Inc. · Jun 2007